Steven Chang
President
Biotechnology
Histogen, Inc
United States of America
Biography
In addition to serving as Chairmen of the Board and a Member of the OTC of Histogen, Inc. Dr. Stephen M. Chang, PhD is Vice President, Research and Development for the New York Stem Cell Foundation (NYSCF). Prior to joining NYSCF, Dr. Chang served as Chief Scientific Officer of Stemgent, and was CEO of Multicell Technologies and continues as a director of this company. He has also served as Chief Scientific Officer (CSO) of Stemgent, Inc., CEO of Astral Immunotherapy, CSO and vice president of Canji Inc. / Schering Plough Research Institute and held senior management positions at Chiron and Viagene
Research Interest
Biotechnology
